Meng et al. [31] had speculated that this might due to the high mutation burden and the increase in base substitution; Howitt et al. [32] showed that POLEmut ECs were associated with high neoantigens and elevated CD8+ tumor infiltrating lymphocytes, which was counterbalanced by overexpression of program death-ligand. The gene discussed is CD8A; the disease is neoplasm.